Immunic, Inc. to Participate in Investor Conferences in December
- Tuesday, November 24, 2020, 7:04
- Finance
- Add a comment
NEW YORK, Nov. 24, 2020 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management’s participation in the…
About the Author
adminasapcorp has written 41555 stories on this site.